Myasthenia Gravis Awareness Month (see related guidelines) | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

• Myasthenia Gravis Awareness Month (see related guidelines)

• GUIDELINE SUMMARY
 
• NGC:009085
 
• 2012 MAR 27 (REAFFIRMED 2015 JUL 18)

Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

American Academy of Neurology

Compare

• GUIDELINE SUMMARY
 
• NGC:002052
 
• 2000 JUL (REAFFIRMED 2014 AUG 9)

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

American Academy of Neurology

Compare

• GUIDELINE SUMMARY
 
• NGC:009935
 
• 2013

Care of the patient with myasthenia gravis.

American Association of Neuroscience Nurses

Compare

• GUIDELINE SUMMARY
 
• NGC:011234
 
• 2016 NOV
•  NEATS Assessment
   LEARN MORE ABOUT NEATS ASSESSMENT

Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.

American Society of Health-System Pharmacists; Society of Critical Care Medicine

Compare

• GUIDELINE SUMMARY
 
• NGC:008274
 
• 2011 JAN 18 (REAFFIRMED 2016 NOV 22)

Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

American Academy of Neurology